These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28815376)

  • 1. Evaluation of genetic and non-genetic factors on foot and mouth disease (FMD) virus vaccine-elicited immune response in Hardhenu (Bos taurus x Bos indicus) cattle.
    Manjeet ; Pander BL; Sharma R; Dhaka SS; Magotra A; Dev K
    Trop Anim Health Prod; 2017 Dec; 49(8):1689-1695. PubMed ID: 28815376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herd Immunity Against Foot-and-Mouth Disease Under Different Vaccination Practices in India.
    Sharma GK; Mahajan S; Matura R; Biswal JK; Ranjan R; Subramaniam S; Misri J; Bambal RG; Pattnaik B
    Transbound Emerg Dis; 2017 Aug; 64(4):1133-1147. PubMed ID: 26920973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological responses of cattle inoculated with inactivated trivalent foot-and-mouth disease vaccine at the wildlife-livestock interface of the Kruger National Park, South Africa.
    Lazarus DD; van Schalkwyk OL; Burroughs REJ; Mpehle A; Reininghaus B; Rikhotso O; Heath L; Maree FF; Blignaut B; Fosgate GT
    Prev Vet Med; 2018 Oct; 158():89-96. PubMed ID: 30220400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary.
    Jamal SM; Shah SI; Ali Q; Mehmood A; Afzal M; Afzal M; Dekker A
    Transbound Emerg Dis; 2014 Dec; 61(6):483-9. PubMed ID: 23305464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.
    Knight-Jones TJ; Bulut AN; Gubbins S; Stärk KD; Pfeiffer DU; Sumption KJ; Paton DJ
    Vaccine; 2015 Feb; 33(6):805-11. PubMed ID: 25528523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine.
    Al Amin M; Ali MR; Islam MR; Alam ASMRU; Shill DK; Rahman MS; Siddique MA; Sultana M; Hossain MA
    Vaccine; 2020 Jul; 38(32):4970-4978. PubMed ID: 32535015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BoLA DRB3 alleles with variability in immune response among the crossbred cattle vaccinated for foot-and-mouth disease (FMD).
    Gowane GR; Sharma AK; Sankar M; Narayanan K; Das B; Subramaniam S; Pattnaik B
    Res Vet Sci; 2013 Aug; 95(1):156-63. PubMed ID: 23541924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antibody responses of cattle for foot-and-mouth disease quadrivalent double oil emulsion vaccine.
    Patil PK; Bayry J; Nair SP; Gopalakrishna S; Sajjanar CM; Misra LD; Natarajan C
    Vet Microbiol; 2002 Jun; 87(2):103-9. PubMed ID: 12034538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.
    Dhanesh VV; Hosamani M; Basagoudanavar SH; Saravanan P; Biswal JK; Tamil Selvan RP; Madhavan A; Sehrish K; Sanyal A; Sreenivasa BP
    Appl Microbiol Biotechnol; 2020 Mar; 104(6):2589-2602. PubMed ID: 32002597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle.
    Kotla S; Sanghratna Vishanath B; H J D; K G; V V S S; Reddy GR
    Vet Microbiol; 2016 Sep; 193():106-15. PubMed ID: 27599937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes.
    Cloete M; Dungu B; Van Staden LI; Ismail-Cassim N; Vosloo W
    Onderstepoort J Vet Res; 2008 Mar; 75(1):17-31. PubMed ID: 18575060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E; Li Y; Zamir L; Even-Tov B; Hamblin P; Gelman B; Hammond J; Klement E
    Vaccine; 2013 Jan; 31(6):879-85. PubMed ID: 23246551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.